Neurobiological mechanisms contributing to alcohol-stress-anxiety interactions

Alcohol

Volumn 43, Issue 7, 2009, Pages 509-519

  Silberman, Yuval ^a   Bajo, Michal ^b   Chappell, Ann M ^a   Christian, Daniel T ^a   Cruz, Maureen ^b   Diaz, Marvin R ^a   Kash, Thomas ^c   Lack, Anna K ^a   Messing, Robert O ^d   Siggins, George R ^b   Winder, Danny ^c,e   Roberto, Marisa ^b   McCool, Brian A ^a   Weiner, Jeff L ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acute; Basolateral amygdala; Bed nucleus of the stria terminalis; Central nucleus of the amygdala; Chronic ethanol; CRF; Dopamine; GABA; Glutamate; Withdrawal

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ALCOHOL; BACLOFEN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; DOPAMINE 1 RECEPTOR; GLUTAMIC ACID; PROTEIN KINASE C EPSILON; UROCORTIN;

4 AMINOBUTYRIC ACID RELEASE; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; AMYGDALOID NUCLEUS; ANXIETY; DOPAMINERGIC TRANSMISSION; DRINKING BEHAVIOR; GABAERGIC TRANSMISSION; LONG TERM POTENTIATION; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; STRESS; STRIA TERMINALIS; SYNAPTIC TRANSMISSION; WITHDRAWAL SYNDROME;

ALCOHOLISM; AMYGDALA; ANIMALS; ANXIETY; CORTICOTROPIN-RELEASING HORMONE; ETHANOL; GAMMA-AMINOBUTYRIC ACID; HUMANS; PROTEIN KINASE C-EPSILON; RECEPTORS, GABA-B; STRESS, PSYCHOLOGICAL; SYNAPTIC TRANSMISSION;

MARISA;

EID: 70350786678     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.alcohol.2009.01.002     Document Type: Review

References (117)

1. Addolorato G., Caputo F., Capristo E., Domenicali M., Bernardi M., Janiri L., et al. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. Alcohol Alcohol. 37 (2002) 504-508
2. Addolorato G., Caputo F., Capristo E., Janiri L., Bernardi M., Agabio R., et al. Rapid suppression of alcohol withdrawal syndrome by baclofen. Am. J. Med. 112 (2002) 226-229
3. Aggleton J.P., Burton M.J., and Passingham R.E. Cortical and subcortical afferents to the amygdala of the rhesus monkey (Macaca mulatta). Brain Res 190 (1980) 347-360
4. Ariwodola O.J., and Weiner J.L. Ethanol potentiation of GABAergic synaptic transmission may be self-limiting: role of presynaptic GABA(B) receptors. J. Neurosci. 24 (2004) 10679-10686
5. Bajo M., Cruz M.T., Siggins G.R., Messing R., and Roberto M. Protein kinase C epsilon mediation of CRF- and ethanol-induced GABA release in central amygdala. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 8410-8415
6. Balleine B.W., and Killcross S. Parallel incentive processing: an integrated view of amygdala function. Trends Neurosci. 29 (2006) 272-279
7. Becker H.C., and Hale R.L. Repeated episodes of ethanol withdrawal potentiate the severity of subsequent withdrawal seizures: an animal model of alcohol withdrawal "kindling". Alcohol. Clin. Exp. Res. 17 (1993) 94-98
8. Becker H.C., and Lopez M.F. Increased ethanol drinking after repeated chronic ethanol exposure and withdrawal experience in C57BL/6 mice. Alcohol. Clin. Exp. Res. 28 (2004) 1829-1838
9. Borgland S.L., Taha S.A., Sarti F., Fields H.L., and Bonci A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49 (2006) 589-601
10. Bradizza C.M., Stasiewicz P.R., and Paas N.D. Relapse to alcohol and drug use among individuals diagnosed with co-occurring mental health and substance use disorders: a review. Clin. Psychol. Rev. 26 (2006) 162-178
11. Brunton L., Parker K., Lazo J., Buxton I., and Blumenthal D. Goodman and Gilman's Pharmacological Basis of Therapeutics. 11 ed. (2005), McGraw-Hill
12. Carboni E., Silvagni A., Rolando M.T., and Di Chiara G. Stimulation of in vivo dopamine transmission in the bed nucleus of stria terminalis by reinforcing drugs. J. Neurosci. 20 (2000) RC102
13. Cassell M.D., Freedman L.J., and Shi C. The intrinsic organization of the central extended amygdala. Ann. N.Y. Acad. Sci. 877 (1999) 217-241
14. Chalmers D.T., Lovenberg T.W., Grigoriadis D.E., Behan D.P., and De Souza E.B. Corticotrophin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol. Sci. 17 (1996) 166-172
15. Cheun J.E., and Yeh H.H. Noradrenergic potentiation of cerebellar Purkinje cell responses to GABA: cyclic AMP as intracellular intermediary. Neuroscience 74 (1996) 835-844
16. Choi D.S., Wang D., Dadgar J., Chang W.S., and Messing R.O. Conditional rescue of protein kinase C epsilon regulates ethanol preference and hypnotic sensitivity in adult mice. J. Neurosci. 22 (2002) 9905-9911
17. Chu K., Koob G.F., Cole M., Zorrilla E.P., and Roberts A.J. Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockout. Pharmacol. Biochem. Behav. 86 (2007) 813-821
18. Colombo G., Addolorato G., Agabio R., Carai M.A., Pibiri F., Serra S., et al. Role of GABA(B) receptor in alcohol dependence: reducing effect of baclofen on alcohol intake and alcohol motivational properties in rats and amelioration of alcohol withdrawal syndrome and alcohol craving in human alcoholics. Neurotox. Res. 6 (2004) 403-414
19. Cosci F., Schruers K.R., Abrams K., and Griez E.J. Alcohol use disorders and panic disorder: a review of the evidence of a direct relationship. J. Clin. Psychiatry 68 (2007) 874-880
20. Davis L.L., Trivedi M., Choate A., Kramer G.L., and Petty F. Growth hormone response to the GABAB agonist baclofen in major depressive disorder. Psychoneuroendocrinology 22 (1997) 129-140
21. Davis M., Rainnie D., and Cassell M. Neurotransmission in the rat amygdala related to fear and anxiety. Trends Neurosci. 17 (1994) 208-214
22. Day H.E., Curran E.J., Watson Jr. S.J., and Akil H. Distinct neurochemical populations in the rat central nucleus of the amygdala and bed nucleus of the stria terminalis: evidence for their selective activation by interleukin-1beta. J. Comp. Neurol. 413 (1999) 113-128
23. Dumont E.C., Mark G.P., Mader S., and Williams J.T. Self-administration enhances excitatory synaptic transmission in the bed nucleus of the stria terminalis. Nat. Neurosci. 8 (2005) 413-414
24. Eiler II W.J., Seyoum R., Foster K.L., Mailey C., and June H.L. D1 dopamine receptor regulates alcohol-motivated behaviors in the bed nucleus of the stria terminalis in alcohol-preferring (P) rats. Synapse 48 (2003) 45-56
25. Fadda F., Mosca E., Meloni R., and Gessa G.L. Suppression by progabide of ethanol withdrawal syndrome in rats. Eur. J. Pharmacol. 109 (1985) 321-325
26. Fallon J.H., Koziell D.A., and Moore R.Y. Catecholamine innervation of the basal forebrain. II. Amygdala, suprarhinal cortex and entorhinal cortex. J. Comp. Neurol. 180 (1978) 509-532
27. Flannery B.A., Garbutt J.C., Cody M.W., Renn W., Grace K., Osborne M., et al. Baclofen for alcohol dependence: a preliminary open-label study. Alcohol. Clin. Exp. Res. 28 (2004) 1517-1523
28. Fox H.C., Bergquist K.L., Hong K.I., and Sinha R. Stress-induced and alcohol cue-induced craving in recently abstinent alcohol-dependent individuals. Alcohol. Clin. Exp. Res. 31 (2007) 395-403
29. Fuchs R.A., Feltenstein M.W., and See R.E. The role of the basolateral amygdala in stimulus-reward memory and extinction memory consolidation and in subsequent conditioned cued reinstatement of cocaine seeking. Eur. J. Neurosci. 23 (2006) 2809-2813
30. Funk C.K., Zorrilla E.P., Lee M.J., Rice K.C., and Koob G.F. Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol. Psychiatry 61 (2007) 78-86
31. Georges F., and Aston-Jones G. Activation of ventral tegmental area cells by the bed nucleus of the stria terminalis: a novel excitatory amino acid input to midbrain dopamine neurons. J. Neurosci. 22 (2002) 5173-5187
32. Gilpin N.W., Richardson H.N., and Koob G.F. Effects of CRF1-receptor and opioid-receptor antagonists on dependence-induced increases in alcohol drinking by alcohol-preferring (P) rats. Alcohol. Clin. Exp. Res. 32 (2008) 1535-1542
33. Grueter B.A., McElligott Z.A., Robison A.J., Mathews G.C., and Winder D.G. In vivo metabotropic glutamate receptor 5 (mGluR5) antagonism prevents cocaine-induced disruption of postsynaptically maintained mGluR5-dependent long-term depression. J. Neurosci. 28 (2008) 9261-9270
34. Heilig M., and Egli M. Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacol. Ther. 111 (2006) 855-876
35. Heilig M., and Koob G.F. A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci. 30 (2007) 399-406
36. Hodge C.W., Mehmert K.K., Kelley S.P., McMahon T., Haywood A., Olive M.F., et al. Supersensitivity to allosteric GABA(A) receptor modulators and alcohol in mice lacking PKCepsilon. Nat. Neurosci. 2 (1999) 997-1002
37. Hodge C.W., Raber J., McMahon T., Walter H., Sanchez-Perez A.M., Olive M.F., et al. Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase Cepsilon. J. Clin. Invest. 110 (2002) 1003-1010
38. Holsboer F., and Ising M. Central CRH system in depression and anxiety-evidence from clinical studies with CRH1 receptor antagonists. Eur. J. Pharmacol. 583 (2008) 350-357
39. Hyytia P., and Koob G.F. GABAA receptor antagonism in the extended amygdala decreases ethanol self-administration in rats. Eur. J. Pharmacol. 283 (1995) 151-159
40. Kageyama K., Hanada K., Moriyama T., Imaizumi T., Satoh K., and Suda T. Differential regulation of CREB and ERK phosphorylation through corticotropin-releasing factor receptors type 1 and 2 in AtT-20 and A7r5 cells. Mol. Cell. Endocrinol. 263 (2007) 90-102
41. Kang M.H., Spigelman I., and Olsen R.W. Alteration in the sensitivity of GABA(A) receptors to allosteric modulatory drugs in rat hippocampus after chronic intermittent ethanol treatment. Alcohol. Clin. Exp. Res. 22 (1998) 2165-2173
42. Kash T.L., Nobis W.P., Matthews R.T., and Winder D.G. Dopamine enhances fast excitatory synaptic transmission in the extended amygdala by a CRF-R1-dependent process. J. Neurosci. 28 (2008) 13856-13865
43. Kessler R.C., Crum R.M., Warner L.A., Nelson C.B., Schulenberg J., and Anthony J.C. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch. Gen. Psychiatry 54 (1997) 313-321
44. Kim Y., Park M.K., Uhm D.Y., and Chung S. Modulation of T-type Ca2+ channels by corticotropin-releasing factor through protein kinase C pathway in MN9D dopaminergic cells. Biochem. Biophys. Res. Commun. 358 (2007) 796-801
45. Kliethermes C.L. Anxiety-like behaviors following chronic ethanol exposure. Neurosci. Biobehav. Rev. 28 (2005) 837-850
46. Koob G.F. A role for GABA mechanisms in the motivational effects of alcohol. Biochem. Pharmacol. 68 (2004) 1515-1525
47. Koob G.F., and Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24 (2001) 97-129
48. Koob G.F., and Le Moal M. Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nat. Neurosci. 8 (2005) 1442-1444
49. Koob G.F., and Le Moal M. Addiction and the Brain Antireward System. Annu. Rev. Psychol. 59 (2008) 29-53
50. Krettek J.E., and Price J.L. Amygdaloid projections to subcortical structures within the basal forebrain and brainstem in the rat and cat. J. Comp. Neurol. 178 (1978) 225-254
51. Kushner M.G., Abrams K., and Borchardt C. The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings. Clin. Psychol. Rev. 20 (2000) 149-171
52. Kushner M.G., Abrams K., Thuras P., Hanson K.L., Brekke M., and Sletten S. Follow-up study of anxiety disorder and alcohol dependence in comorbid alcoholism treatment patients. Alcohol. Clin. Exp. Res. 29 (2005) 1432-1443
53. Kushner M.G., Abrams K., Thuras P., Thuras P., and Hanson K.L. Individual differences predictive of drinking to manage anxiety among non-problem drinkers with panic disorder. Alcohol. Clin. Exp. Res. 24 (2000) 448-458
54. Kushner M.G., Sher K.J., and Erickson D.J. Prospective analysis of the relation between DSM-III anxiety disorders and alcohol use disorders. Am. J. Psychiatry 156 (1999) 723-732
55. Lack A.K., Ariwodola O.J., Chappel A., Weiner J.L., and McCool B.A. Ethanol inhibition of kainate receptor-mediated excitatory neurotransmission in the rat basolateral nucleus of the amygdala. Neuropharmacology. 55 (2008) 661-668
56. Lack, A. K., Christian, D. T., Diaz, M. R., & McCool, B. A. Chronic ethanol and withdrawal effects on kainate receptor mediated excitatory neurotransmission in the rat basolateral amygdala. Alcohol. 43, 25-33.
57. Lack A.K., Diaz M.R., Chappell A., DuBois D.W., and McCool B.A. Chronic ethanol and withdrawal differentially modulate pre- and postsynaptic function at glutamatergic synapses in rat basolateral amygdala. J. Neurophysiol. 98 (2007) 3185-3196
58. LeDoux J.E. Emotional memory: in search of systems and synapses. Ann. N.Y. Acad. Sci. 702 (1993) 149-157
59. Le Moal M., and Koob G.F. Drug addiction: pathways to the disease and pathophysiological perspectives. Eur. Neuropsychopharmacol. 17 (2007) 377-393
60. Li H., and Rogawski M.A. GluR5 kainate receptor mediated synaptic transmission in rat basolateral amygdala in vitro. Neuropharmacology 37 (1998) 1279-1286
61. Li H., Weiss S.R., Chuang D.M., Post R.M., and Rogawski M.A. Bidirectional synaptic plasticity in the rat basolateral amygdala: characterization of an activity-dependent switch sensitive to the presynaptic metabotropic glutamate receptor antagonist 2S-alpha-ethylglutamic acid. J. Neurosci. 18 (1998) 1662-1670
62. Lin A.M., Freund R.K., and Palmer M.R. Ethanol potentiation of GABA-induced electrophysiological responses in cerebellum: requirement for catecholamine modulation. Neurosci. Lett. 122 (1991) 154-158
63. Li Q., Wilson W.A., and Swartzwelder H.S. Developmental differences in the sensitivity of spontaneous and miniature IPSCs to ethanol. Alcohol. Clin. Exp. Res. 30 (2006) 119-126
64. Lopez M.F., and Becker H.C. Effect of pattern and number of chronic ethanol exposures on subsequent voluntary ethanol intake in C57BL/6J mice. Psychopharmacology (Berl.) 181 (2005) 688-696
65. Lowery E.G., Sparrow A.M., Breese G.R., Knapp D.J., and Thiele T.E. The CRF-1 receptor antagonist, CP-154,526, attenuates stress-induced increases in ethanol consumption by BALB/cJ mice. Alcohol. Clin. Exp. Res. 32 (2008) 240-248
66. Marinelli P.W., Funk D., Juzytsch W., Harding S., Rice K.C., Shaham Y., et al. The CRF1 receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats. Psychopharmacology (Berl.) 195 (2007) 345-355
67. Marowsky A., Yanagawa Y., Obata K., and Vogt K.E. A specialized subclass of interneurons mediates dopaminergic facilitation of amygdala function. Neuron 48 (2005) 1025-1037
68. Mascagni F., and McDonald A.J. Immunohistochemical characterization of cholecystokinin containing neurons in the rat basolateral amygdala. Brain Res. 976 (2003) 171-184
69. McDonald A.J., and Mascagni F. Immunohistochemical characterization of somatostatin containing interneurons in the rat basolateral amygdala. Brain Res. 943 (2002) 237-244
70. Menard J., and Treit D. Effects of centrally administered anxiolytic compounds in animal models of anxiety. Neurosci. Biobehav. Rev. 23 (1999) 591-613
71. Merlo Pich E., Lorang M., Yeganeh M., Rodriguez de Fonseca F., Raber J., Koob G.F., et al. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J. Neurosci. 15 (1995) 5439-5447
72. Miller W.R., and Harris R.J. A simple scale of Gorski's warning signs for relapse. J. Stud. Alcohol 61 (2000) 759-765
73. Muller J.F., Mascagni F., and McDonald A.J. Postsynaptic targets of somatostatin-containing interneurons in the rat basolateral amygdala. J. Comp. Neurol. 500 (2007) 513-529
74. Nie Z., Schweitzer P., Roberts A.J., Madamba S.G., Moore S.D., and Siggins G.R. Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors. Science 303 (2004) 1512-1514
75. North R.A., Williams J.T., Surprenant A., and Christie M.J. Mu and delta receptors belong to a family of receptors that are coupled to potassium channels. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 5487-5491
76. Nose I., Higashi H., Inokuchi H., and Nishi S. Synaptic responses of guinea pig and rat central amygdala neurons in vitro. J. Neurophysiol. 65 (1991) 1227-1241
77. Olive M.F., Koenig H.N., Nannini M.A., and Hodge C.W. Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacol. Biochem. Behav. 72 (2002) 213-220
78. Olive M.F., Mehmert K.K., Messing R.O., and Hodge C.W. Reduced operant ethanol self-administration and in vivo mesolimbic dopamine responses to ethanol in PKCepsilon-deficient mice. Eur. J. Neurosci. 12 (2000) 4131-4140
79. Olive M.F., and Messing R.O. Protein kinase C isozymes and addiction. Mol. Neurobiol. 29 (2004) 139-154
80. Overstreet D.H., Knapp D.J., and Breese G.R. Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors. Pharmacol. Biochem. Behav. 77 (2004) 405-413
81. Palchaudhuri M.R., Wille S., Mevenkamp G., Spiess J., Fuchs E., and Dautzenberg F.M. Corticotropin-releasing factor receptor type 1 from Tupaia belangeri-cloning, functional expression and tissue distribution. Eur. J. Biochem. 258 (1998) 78-84
82. Panchenko V.A., Glasser C.R., Partin K.M., and Mayer M.L. Amino acid substitutions in the pore of rat glutamate receptors at sites influencing block by polyamines. J. Physiol. 520 Pt 2 (1999) 337-357
83. Phelix C.F., Chen H., Trevino G., Lara J.R., Liu G., and Wayner M.J. Bicuculline sensitive depressor response to ethanol infusion into the lateral hypothalamus. Alcohol 19 (1999) 177-185
84. Piazza P.V., and Le Moal M. The role of stress in drug self-administration. Trends Pharmacol. Sci. 19 (1998) 67-74
85. Porrino L.J., Crane A.M., and Goldman-Rakic P.S. Direct and indirect pathways from the amygdala to the frontal lobe in rhesus monkeys. J. Comp. Neurol. 198 (1981) 121-136
86. Potter E., Sutton S., Donaldson C., Chen R., Perrin M., Lewis K., et al. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8777-8781
87. Rassnick S., Heinrichs S.C., Britton K.T., and Koob G.F. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res. 605 (1993) 25-32
88. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264 (1990) 2511-2518
89. Rizos Z., Ovari J., and Leri F. Reconditioning of heroin place preference requires the basolateral amygdala. Pharmacol. Biochem. Behav. 82 (2005) 300-305
90. Roberts A.J., Cole M., and Koob G.F. Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats. Alcohol. Clin. Exp. Res. 20 (1996) 1289-1298
91. Roberts A.J., Heyser C.J., Cole M., Griffin P., and Koob G.F. Excessive ethanol drinking following a history of dependence: animal model of allostasis. Neuropsychopharmacology 22 (2000) 581-594
92. Roberts A.J., Phillips T.J., Belknap J.K., Finn D.A., and Keith L.D. Genetic analysis of the corticosterone response to ethanol in BXD recombinant inbred mice. Behav. Neurosci. 109 (1995) 1199-1208
93. Roberto M., Madamba S.G., Stouffer D.G., Parsons L.H., and Siggins G.R. Increased GABA release in the central amygdala of ethanol-dependent rats. J. Neurosci. 24 (2004) 10159-10166
94. Roder S., and Ciriello J. Innervation of the amygdaloid complex by catecholaminergic cell groups of the ventrolateral medulla. J. Comp. Neurol. 332 (1993) 105-122
95. Sah P., Faber E.S., Lopez De Armentia M., and Power J. The amygdaloid complex: anatomy and physiology. Physiol. Rev. 83 (2003) 803-834
96. Sajdyk T.J., and Shekhar A. Excitatory amino acid receptor antagonists block the cardiovascular and anxiety responses elicited by gamma-aminobutyric acid-A receptor blockade in the basolateral amygdala of rats. J. Pharmacol. Exp. Ther. 283 (1997) 969-977
97. Sajdyk T.J., and Shekhar A. Excitatory amino acid receptors in the basolateral amygdala regulate anxiety responses in the social interaction test. Brain Res. 764 (1997) 262-264
98. Samson H.H., Hodge C.W., Erickson H.L., Niehus J.S., Gerhardt G.A., Kalivas P.W., et al. The effects of local application of ethanol in the n. accumbens on dopamine overflow and clearance. Alcohol 14 (1997) 485-492
99. A receptors in the rat amygdala. Pharmacol. Biochem. Behav. 52 (1995) 701-706
100. Santucci A.C., Cortes C., Bettica A., and Cortes F. Chronic ethanol consumption in rats produces residual increases in anxiety 4 months after withdrawal. Behav. Brain Res. 188 (2008) 24-31
101. Siggins G.R., Roberto M., and Nie Z. The tipsy terminal: presynaptic effects of ethanol. Pharmacol. Ther. 107 (2005) 80-98
102. Silberman Y., Shi L., Brunso-Bechtold J.K., and Weiner J.L. Distinct mechanisms of ethanol potentiation of local and paracapsular GABAergic synapses in the rat basolateral amygdala. J. Pharmacol. Exp. Ther. 324 (2008) 251-260
103. Sinha R., and Li C.S. Imaging stress- and cue-induced drug and alcohol craving: association with relapse and clinical implications. Drug Alcohol Rev. 26 (2007) 25-31
104. Sun N., and Cassell M.D. Intrinsic GABAergic neurons in the rat central extended amygdala. J. Comp. Neurol. 330 (1993) 381-404
105. Takahashi L.K. Role of CRF(1) and CRF(2) receptors in fear and anxiety. Neurosci. Biobehav. Rev. 25 (2001) 627-636
106. Thomas M.J., Beurrier C., Bonci A., and Malenka R.C. Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine. Nat. Neurosci. 4 (2001) 1217-1223
107. Tye K.M., Stuber G.D., de Ridder B., Bonci A., and Janak P.H. Rapid strengthening of thalamo-amygdala synapses mediates cue-reward learning. Nature 453 (2008) 1253-1257
108. Valdez G.R., Roberts A.J., Chan K., Davis H., Brennan M., Zorrilla E.P., et al. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol. Clin. Exp. Res. 26 (2002) 1494-1501
109. Walker D.L., and Davis M. The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction. Pharmacol. Biochem. Behav. 71 (2002) 379-392
110. Walker D.L., and Davis M. Role of the extended amygdala in short-duration versus sustained fear: a tribute to Dr. Lennart Heimer. Brain Struct. Funct. 213 (2008) 29-42
111. Washburn M.S., and Moises H.C. Electrophysiological and morphological properties of rat basolateral amygdaloid neurons in vitro. J. Neurosci. 12 (1992) 4066-4079
112. Watanabe Y., Ikegaya Y., Saito H., and Abe K. Opposite regulation by the β-adrenoceptor-cyclic amp system of synaptic plasticity in the medial and lateral amygdala in vitro. Neurosci. 71 (1990) 1031-1035
113. Watkins S.S., Epping-Jordan M.P., Koob G.F., and Markou A. Blockade of nicotine self-administration with nicotinic antagonists in rats. Pharmacol. Biochem. Behav. 62 (1999) 743-751
114. Weiner J.L., and Valenzuela C.F. Ethanol modulation of GABAergic transmission: the view from the slice. Pharmacol. Ther. 111 (2006) 533-554
115. Weiss F., Ciccocioppo R., Parsons L.H., Katner S., Liu X., Zorrilla E.P., et al. Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Ann. N.Y. Acad. Sci. 937 (2001) 1-26
116. Willinger U., Lenzinger E., Hornik K., Fischer G., Schonbeck G., Aschauer H.N., et al. Anxiety as a predictor of relapse in detoxified alcohol-dependent patients. Alcohol Alcohol. 37 (2002) 609-612
117. Woodruff A.R., and Sah P. Networks of parvalbumin-positive interneurons in the basolateral amygdala. J. Neurosci. 27 (2007) 553-563